IEX •
Healthcare •
Biotechnology •
Quote as of 08/19/2026 15:59
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization3,409.52 mln
Float209 mln
Earnings Date11/10/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-2.26
Borderline
1-Year Forecast
17.12
Exceptional upside
Relative Strength
100
/ 100
Top performer
Debt / Equity
0.15
Very low leverage
ROE
-17.25
Negative
Business Description
AbCellera Biologics is a Canadian biotechnology company focused on finding and building new antibody-based treatments for patients who currently have few or no good options. The company has two drugs in clinical testing: one aimed at relieving hot flashes and night sweats without using hormones, and another designed to treat immune-related skin conditions like eczema. AbCellera works alongside several major pharmaceutical and investment partners, including Eli Lilly, AbbVie, and Biogen, and operates out of its headquarters in Vancouver, Canada.
